Literature DB >> 1083526

Antigen stimulation of prostaglandin synthesis and control of immune responses.

D R Webb, P L Osheroff.   

Abstract

Within 2 min following the intravenous injection of sheep erythrocytes (sRBC) there occurs 20 to 80-fold increase in prostaglandin (PG) F2alpha in the spleen. This burst of synthesis is followed by a slow decline to control levels over the next 1-4 hr. No increase in splenic PGF2alpha levels is observed between 24 and 72 hr after injection. Injection of colloidal carbon results in a small increase, approximately 20% of the increase in PGF2alpha observed with sRBC. The early increase in splenic PGF2alpha levels stimulated by sRBC is also dependent upon thymus-derived (T) cells, since the increase is small or nonexistent in athymic mice and NZB mice. Also, the elevation of splenic PGF2alpha levels is blocked by the administration of indomethacin or Ro 20-5720, both of which block the synthesis of prostglandin. A small increase (2-fold) in PGF2alpha levels occurs in the thymus. A soluble antigen, bovine gamma globulin, stimulated a bimodal increase in splenic PGF2alpha levels, the early peak occurring at 2 hr and the later increase occurring at 48 hr. Using inhibitors of prostaglandin synthesis, it is possible to enhance the appearance of cells forming 19S antibody against sRBC, both in vivo and in vitro. Furthermore, inhibition of prostaglandin synthesis enhances DNA synthesis induced in a two-way mixed-lymphocyte reaction only in whole spleen cell cultures and not in cultures of spleen cells purified by passage over glass wool. Based on this evidence, it is proposed that the prostaglandins represent a major soluble mediator in the control of T cell-T cell interactions and also play an important part in T-B (bone-marrow derived) cell interactions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1083526      PMCID: PMC430253          DOI: 10.1073/pnas.73.4.1300

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  T-cell regulation of immune responsiveness.

Authors:  J F Miller
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

2.  Antigen-stimulated changes in cyclic nucleotide levels in the mouse.

Authors:  I Yamamoto; D R Webb
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

3.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

Review 4.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

5.  Precipitation of radioactively labeled samples: a semi-automatic multiple-sample processor.

Authors:  R J Hartzman; M L Bach; F H Bach; G B Thurman; K W Sell
Journal:  Cell Immunol       Date:  1972-06       Impact factor: 4.868

6.  Alteration of the cytotoxic action of sensitized lymphocytes by cholinergic agents and activators of adenylate cyclase.

Authors:  T B Strom; A Deisseroth; J Morganroth; C B Carpenter; J P Merrill
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

7.  Histamine release in vitro: inhibition by catecholamines and methylxanthines.

Authors:  L M Lichtenstein; S Margolis
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

8.  Release of prostaglandin by mitogen- and antigen-stimulated leukocytes in culture.

Authors:  V A Ferraris; F R DeRubertis
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

9.  Cellular recognition by mouse lymphocytes in vitro. I. Definition of a new technique and results of stimulation by phytohemagglutinin and specific antigens.

Authors:  W H Adler; T Takiguchi; B Marsh; R T Smith
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  35 in total

1.  A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin.

Authors:  M Torbinejad; J Clagett; D Engel
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

2.  The effect of a single whole-blood transfusion on cytokine secretion.

Authors:  Y Kalechman; U Gafter; D Sobelman; B Sredni
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

Review 3.  Control of humoral immune responses by arachidonic acid metabolites.

Authors:  T W Behrens; J S Goodwin
Journal:  Agents Actions       Date:  1989-01

4.  Pharmacological control of the hormonally modulated immune response. II. Blockade of antibody production by a combination of drugs acting on neuroendocrine functions. Its prevention by gonadotropins and corticotrophin.

Authors:  W Pierpaoli; G J Maestroni
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

5.  The spleen is required for the suppression of experimental allergic encephalomyelitis by prostaglandin precursors.

Authors:  J Mertin; A Stackpoole
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

6.  Modulation by thymus-derived (T) cells of thyroid cell-stimulated prostaglandin E release by human peripheral blood mononuclear cells.

Authors:  M Yamamoto; N A Takai; B Rapoport; W E Hinds
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

7.  Regulation of human immunoglobulin production in vitro by prostaglandin E2.

Authors:  N D Staite; G S Panayi
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  Enhancement of lymphocyte blastogenic and delayed hypersensitivity skin responses by indomethacin.

Authors:  C C Muscoplat; P M Rakich; C O Thoen; D W Johnson
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

9.  Indomethacin inhibits in vitro immunoglobulin production by human B-lymphocytes.

Authors:  G S Panayi; N D Staite; A Unger
Journal:  Agents Actions       Date:  1981-12

10.  In vitro suppression of myelopoiesis by adherent murine splenocytes in experimental disseminated histoplasmosis.

Authors:  C W Caldwell; Y W Yesus; R F Sprouse
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.